InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,915.30
(
0.04%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: Investor100 post# 437

Thursday, 07/14/2016 7:38:28 PM

Thursday, July 14, 2016 7:38:28 PM

Post# of 13959
Immune Pharmaceuticals Inc. (NASDAQ:IMNP) Annual EBIT At $-15.724 Millions

We run tomorrow!

http://theenterpriseleader.com/analyst-research/immune-pharmaceuticals-inc-nasdaqimnp-annual-ebit-at-15-724-millions/126540/

EBITDA and EBITDA margins

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) reported EBITDA of $-15.724 millions for the fiscal closed 2015-12-31. For the quarter closed 2015-12-31, it was -15.724 millions. EBITDA margin stood at -15.724% for the fiscal ended 2015-12-31.

Investor 100
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up